MR

Madhusudhana Reddy Kommepalli

Active Director Director DIN 09206692
DIN 09206692 First appointment Jun 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Madhusudhana Reddy Kommepalli

Data last updated:

Madhusudhana Reddy Kommepalli is a Director at Niar Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare.

DIN 09206692
Primary Designation Director
Industry Healthcare
First Appointment 17 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Niar Pharmaceuticals Private Limited U85110TG2021PTC152343
Director17 Jun 20212021Active

Board colleagues of Madhusudhana Reddy Kommepalli

Directorship timeline

Open interactive timeline →
Niar Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Madhusudhana Reddy Kommepalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhusudhana Reddy Kommepalli

Madhusudhana Reddy Kommepalli currently holds 1 directorship: Niar Pharmaceuticals Private Limited (Director, since 17 Jun 2021).

Madhusudhana Reddy Kommepalli was first appointed on 17 Jun 2021 as Director at Niar Pharmaceuticals Private Limited.

The current boards of Madhusudhana Reddy Kommepalli's companies include Vidya Sagar Reddy Manchuri (Niar Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available